$LSEB
LSEB Creative Corp.

2024 Q1 Form 10-Q Financial Statement

#000119983524000095 Filed on February 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q1
Revenue $2.070K $1.915K $0.00
YoY Change
Cost Of Revenue $810.00 $527.00
YoY Change
Gross Profit $1.260K $1.388K
YoY Change
Gross Profit Margin 60.87% 72.48%
Selling, General & Admin $43.52K $29.56K $32.95K
YoY Change 32.08% -17.01%
% of Gross Profit 3453.97% 2129.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $500.00 $60.00 $80.00
YoY Change 525.0% -33.33%
% of Gross Profit 39.68% 4.32%
Operating Expenses $44.02K $29.63K $33.04K
YoY Change 33.23% -17.03%
Operating Profit -$42.76K -$28.24K
YoY Change -20.91%
Interest Expense -$1.260K $1.330K $430.00
YoY Change -393.02% -529.03%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$44.01K -$26.91K -$32.61K
YoY Change 34.96% -25.29%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$44.01K -$26.91K -$32.61K
YoY Change 34.96% -25.29%
Net Earnings / Revenue -2126.09% -1405.17%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 14.68M shares 14.66M shares 13.47M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.450K $810.00 $2.710K
YoY Change 64.21% -98.69%
Cash & Equivalents $4.448K $814.00 $2.710K
Short-Term Investments
Other Short-Term Assets $15.32K $16.50K $145.1K
YoY Change -89.44% -48.82%
Inventory $130.0K $130.8K $3.526K
Prepaid Expenses
Receivables $1.731K $255.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $151.5K $148.4K $151.3K
YoY Change 0.13% 52.01% 146.01%
LONG-TERM ASSETS
Property, Plant & Equipment $3.242K $796.00 $1.007K
YoY Change 221.95% -26.91% -26.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.242K $796.00 $1.007K
YoY Change 221.95% -26.91% -26.76%
TOTAL ASSETS
Total Short-Term Assets $151.5K $148.4K $151.3K
Total Long-Term Assets $3.242K $796.00 $1.007K
Total Assets $154.7K $149.2K $152.3K
YoY Change 1.6% 51.14% 142.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.881K $7.223K $5.095K
YoY Change 15.43% 82.49% -62.86%
Accrued Expenses $11.88K $4.259K $8.109K
YoY Change 46.47% 17.42%
Deferred Revenue
YoY Change
Short-Term Debt $69.47K $63.75K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $89.23K $75.23K $69.97K
YoY Change 27.52% 627.22% 359.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $89.23K $75.23K $69.97K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $89.23K $75.23K $69.97K
YoY Change 27.53% 626.86%
SHAREHOLDERS EQUITY
Retained Earnings -$554.5K -$510.5K -$391.0K
YoY Change 41.83% 42.46% 58.54%
Common Stock $1.504K $1.468K $1.357K
YoY Change 10.83% 10.13% 12.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $65.51K $73.94K $82.33K
YoY Change
Total Liabilities & Shareholders Equity $154.7K $149.2K $152.3K
YoY Change 1.6% 51.14% 142.23%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q1
OPERATING ACTIVITIES
Net Income -$44.01K -$26.91K -$32.61K
YoY Change 34.96% -25.29%
Depreciation, Depletion And Amortization $500.00 $60.00 $80.00
YoY Change 525.0% -33.33%
Cash From Operating Activities -$24.52K -$12.30K -$141.0K
YoY Change -82.61% -79.43%
INVESTING ACTIVITIES
Capital Expenditures $2.950K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.950K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 31.10K -110.0 81.83K
YoY Change -61.99% -100.14%
NET CHANGE
Cash From Operating Activities -24.52K -12.30K -141.0K
Cash From Investing Activities -2.950K 0.000
Cash From Financing Activities 31.10K -110.0 81.83K
Net Change In Cash 3.630K -12.41K -59.14K
YoY Change -106.14% -170.19%
FREE CASH FLOW
Cash From Operating Activities -$24.52K -$12.30K -$141.0K
Capital Expenditures $2.950K $0.00
Free Cash Flow -$27.47K -$141.0K
YoY Change -80.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001888740
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
lseb Changes In Stock Receivable Subscription
ChangesInStockReceivableSubscription
usd
lseb Changes In Stock Receivable Subscription
ChangesInStockReceivableSubscription
usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
usd
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Entity File Number
EntityFileNumber
333-260873
dei Entity Registrant Name
EntityRegistrantName
LSEB CREATIVE CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-4415385
dei Entity Address Address Line1
EntityAddressAddressLine1
30 N. Gould St. #4000
dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan
dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
701-8561
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14680500 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
814 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2710 usd
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
15143 usd
CY2023Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
141362 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
255 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
130802 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
3526 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1358 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3695 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
148372 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
151293 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
796 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1007 usd
CY2023Q4 us-gaap Assets
Assets
149168 usd
CY2023Q1 us-gaap Assets
Assets
152300 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7223 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5095 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4259 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8109 usd
CY2023Q4 lseb Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
63749 usd
CY2023Q1 lseb Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
56767 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75231 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
69971 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14680500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14680500 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13569000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13569000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1468 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1357 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
582991 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
471953 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-510522 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-390981 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
73937 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82329 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149168 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152300 usd
CY2023Q4 us-gaap Revenues
Revenues
1915 usd
us-gaap Revenues
Revenues
1915 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
527 usd
us-gaap Cost Of Revenue
CostOfRevenue
527 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
1388 usd
us-gaap Gross Profit
GrossProfit
1388 usd
CY2023Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4400 usd
CY2022Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3338 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
42370 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
7417 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11174 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5326 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39742 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22447 usd
CY2023Q4 lseb Consulting Expenses
ConsultingExpenses
6021 usd
CY2022Q4 lseb Consulting Expenses
ConsultingExpenses
21111 usd
lseb Consulting Expenses
ConsultingExpenses
19090 usd
lseb Consulting Expenses
ConsultingExpenses
44399 usd
CY2023Q4 us-gaap Legal Fees
LegalFees
7968 usd
CY2022Q4 us-gaap Legal Fees
LegalFees
5845 usd
us-gaap Legal Fees
LegalFees
18992 usd
us-gaap Legal Fees
LegalFees
31858 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
65 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
88 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
211 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
286 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
29628 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
35708 usd
us-gaap Operating Expenses
OperatingExpenses
120405 usd
us-gaap Operating Expenses
OperatingExpenses
106407 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-28240 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-35708 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-119017 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-106407 usd
CY2023Q4 lseb Exchange Gainloss
ExchangeGainloss
-1331 usd
CY2022Q4 lseb Exchange Gainloss
ExchangeGainloss
311 usd
lseb Exchange Gainloss
ExchangeGainloss
524 usd
lseb Exchange Gainloss
ExchangeGainloss
5357 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26909 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36019 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-119541 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111764 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-26909 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-36019 usd
us-gaap Net Income Loss
NetIncomeLoss
-119541 usd
us-gaap Net Income Loss
NetIncomeLoss
-111764 usd
CY2023Q4 lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0019
CY2022Q4 lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0029
lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0085
lseb Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.0091
CY2023Q4 lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
14023019 shares
CY2022Q4 lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
12261137 shares
lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
14023019 shares
lseb Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
12261137 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82329 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44200 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-31291 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
99738 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
55199 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61341 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
98096 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-26909 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
73937 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
47640 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-36842 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30798 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-38903 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31895 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15000 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
77476 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-36019 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
88352 usd
us-gaap Net Income Loss
NetIncomeLoss
-119541 usd
us-gaap Net Income Loss
NetIncomeLoss
-111764 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
211 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
286 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
15000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-255 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-127276 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3526 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2337 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1904 usd
lseb Increase Decrease In Change In Advances To Suppliers
IncreaseDecreaseInChangeInAdvancesToSuppliers
126219 usd
lseb Increase Decrease In Change In Advances To Suppliers
IncreaseDecreaseInChangeInAdvancesToSuppliers
-26331 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3850 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3627 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2128 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9759 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109027 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-134371 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17358 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
478 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
24340 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1721 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100149 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
137476 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
107131 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138719 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1896 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4348 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2710 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57497 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
814 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61845 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_802_eus-gaap--NatureOfOperations_zIkUQhwEKeil" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.3in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zj3LsrhdoD5">NATURE OF OPERATIONS</span></b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">LSEB Creative Corp. was incorporated as “Profit Corporation” on April 3rd , 2019 under Wyoming State regulations with registered office at 1920 Thomes Ave Ste 610, Cheyenne, WY. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 3, 2023, the Company incorporated its wholly-owned subsidiary 1000615000 Ontario Corp, an Ontario corporation, and on September 12, 2023 filed articles of amendment to changed its name to LSEB Creative Corp (Ontario). The purpose of the subsidiary is for GST/HST tax credits on importing goods into Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">LSEB Creative Corp. is a specialty retailer that offers men and women elevated swimwear designs, constructed with the highest quality materials and techniques. Our product concept focuses on coordinating items within the men’s and women’s sub-categories, which allows customers the ability to coordinate with their partner. It’s this concept, along with our noteworthy fabrics, construction techniques, and “ready-to-wear” inspired designs that will allow LSEB to capture a new space within the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Its aim is to become a leading retailer in the global luxury fashion industry. The corporation is currently involved in concept, design, manufacturing, and distribution of its products with emphasis on its swimwear category. The Company operates under the web-site address lsebcreative.com and its e-commerce platform laurenbentleyswim.com which is complete, and the Company launched the brand in October 2023.</span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
814 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2710 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zpCcTXiEtxWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_864_zyZVLal8BHV1">Reclassification</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain prior year amounts have been reclassified for comparative purposes to conform to the current year financial statement presentation. These reclassifications had no effect on previous reported results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4400 usd
CY2022Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3338 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
42370 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
7417 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zOhwreR2D12i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_863_zhs47WQuMLXk">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of audited financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include deferred income tax assets and related valuation allowance, valuation of convertible notes, warrants and accruals. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p>
CY2023Q4 us-gaap Inventory Net
InventoryNet
130802 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1948 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1737 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
796 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1007 usd
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_84D_eus-gaap--RevenueRecognitionDeferredRevenue_zcMvNQttexY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span style="text-decoration: underline"><span id="xdx_86D_zvUlbVgeaFn5">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company recognizes revenue in accordance with ASC-606 by,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying the contract(s) with a customer,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying the performance obligations in the contract,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining the transaction price,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocating the transaction price to the performance obligations in the contract and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognizing revenue when the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Accordingly, the Company recognizes revenue when performance obligations under the terms of the contracts are satisfied. Our performance obligations primarily consist of delivering products to our customers. Control is transferred upon providing the products to customers upon shipment of our products to the consumers from our ecommerce sites. Once control is transferred to the customer, we have completed our performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
15143 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2744 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1737 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1369 usd
us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
211 usd
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1
368 usd
CY2023Q4 lseb Accounts Payable Related Parties Current1
AccountsPayableRelatedPartiesCurrent1
63749 usd
CY2023Q1 lseb Accounts Payable Related Parties Current1
AccountsPayableRelatedPartiesCurrent1
56767 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
5604 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14680500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14680500 shares
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
37000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3700 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
45000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4500 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
150000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
60000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
75000 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7500 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
47000 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4700 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
80000 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
500 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7500 shares
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
750 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000 usd

Files In Submission

Name View Source Status
0001199835-24-000095-index-headers.html Edgar Link pending
0001199835-24-000095-index.html Edgar Link pending
0001199835-24-000095.txt Edgar Link pending
0001199835-24-000095-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lseb-10q.htm Edgar Link pending
lseb-20231231.xsd Edgar Link pending
lseb-ex31_1.htm Edgar Link pending
lseb-ex31_2.htm Edgar Link pending
lseb-ex32_1.htm Edgar Link pending
lseb-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lseb-10q_htm.xml Edgar Link completed
lseb-20231231_cal.xml Edgar Link unprocessable
lseb-20231231_def.xml Edgar Link unprocessable
lseb-20231231_lab.xml Edgar Link unprocessable
lseb-20231231_pre.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending